Skip to main content
. 2013 Oct 31;15(5):R103. doi: 10.1186/bcr3567

Figure 1.

Figure 1

Overall schema of analysis plan. Blue boxes show the assay platform advancement and the developmental progression of ICS as a prognostic biomarker (discovery, validation and optimization). Black boxes show the signatures assessed at each stage of development.